Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1 Phase 1 1

Status

Recruiting 7 Completed 7 Active not recruiting 7 Terminated 3 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Carboplatin 75 Cisplatin 73 Bevacizumab 64 Radiotherapy 57 Drug Therapy 56 Capecitabine 56 tislelizumab 54 Oxaliplatin 54 Gemcitabine 46 toripalimab 45 Paclitaxel 45 Specimen Handling 43 sintilimab 39 pembrolizumab 39 anlotinib 38 Cyclophosphamide 33 130-nm albumin-bound paclitaxel 32 Magnetic Resonance Spectroscopy 27 Injections 27 camrelizumab 26 Pemetrexed 26 Surgical Procedures, Operative 25 lenvatinib 23 Docetaxel 23 Biopsy 23 apatinib 22 Etoposide 22 Immune Checkpoint Inhibitors 21 S 1 (combination) 20 Fluorouracil 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × tocilizumab × Clear all

NCT07589634 2026-05-15

TRI Pro

Janssen Research & Development, LLC

Phase 2 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡